Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Lemoine

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacological Research|February 16, 2023
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccinesAllegra Peletta, Céline Lemoine, Thomas Courant, et al.
Dalton Transactions (Cambridge, England : 2003)|May 15, 2008
Diphosphine sulfides derived from 2,2'-biphosphole: novel chiral S,S ligands for palladium-catalyzed asymmetric allylic substitutionEmmanuel Robé, Wieslawa Perlikowska, Céline Lemoine, et al.
Scientific Reports|January 13, 2025
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidateMarcellus Korompis, Christopher J De Voss, Shuailin Li, et al.
Pharmaceutics|December 23, 2023
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant ChoiceMohammad Suhail Khan, Virginie Jakob, Randhir Singh, et al.
Vaccines|June 21, 2020
Technological Approaches for Improving Vaccination Compliance and CoverageCéline Lemoine, Aneesh Thakur, Danina Krajišnik, et al.
NPJ Vaccines|October 25, 2023
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variantsNidhi Mittal, Sahil Kumar, Raju S Rajmani, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacological Research|February 16, 2023
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccinesAllegra Peletta, Céline Lemoine, Thomas Courant, et al.
Dalton Transactions (Cambridge, England : 2003)|May 15, 2008
Diphosphine sulfides derived from 2,2'-biphosphole: novel chiral S,S ligands for palladium-catalyzed asymmetric allylic substitutionEmmanuel Robé, Wieslawa Perlikowska, Céline Lemoine, et al.
Scientific Reports|January 13, 2025
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidateMarcellus Korompis, Christopher J De Voss, Shuailin Li, et al.
Pharmaceutics|December 23, 2023
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant ChoiceMohammad Suhail Khan, Virginie Jakob, Randhir Singh, et al.
Vaccines|June 21, 2020
Technological Approaches for Improving Vaccination Compliance and CoverageCéline Lemoine, Aneesh Thakur, Danina Krajišnik, et al.
NPJ Vaccines|October 25, 2023
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variantsNidhi Mittal, Sahil Kumar, Raju S Rajmani, et al.
Pageof 1